HUTCHMED (China) Ltd Files August 2025 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Aug 25, 2025 · CIK: 1648257
Sentiment: neutral
Topics: 6-K, disclosure, foreign-private-issuer
TL;DR
HUTCHMED (China) Ltd filed its monthly 6-K report on 8/25/25. Standard disclosure.
AI Summary
HUTCHMED (China) Limited filed a Form 6-K on August 25, 2025, reporting its activities for the month of August 2025. The company, formerly known as Hutchison China MediTech Ltd, is incorporated in E9 and headquartered in Hong Kong. This filing is a routine report for a foreign private issuer.
Why It Matters
This filing provides an update on the company's ongoing operations and regulatory disclosures as a foreign private issuer, which is important for investors tracking its business activities.
Risk Assessment
Risk Level: low — This is a routine 6-K filing, which typically contains updates on company activities and does not usually involve significant new financial or strategic information that would alter risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Filer
- Hutchison China MediTech Ltd (company) — Former company name
- August 2025 (date) — Reporting period
- 20250825 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the company has made or is required to make public pursuant to the laws of its home country, or that it has filed or is required to file with a stock exchange, or that it has distributed or is required to distribute to its security holders.
When was HUTCHMED (China) Limited previously known by another name?
The company was formerly known as Hutchison China MediTech Ltd, with a name change date of July 16, 2015.
Where is HUTCHMED (China) Limited's principal executive office located?
The principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or Form 40-F?
The filing indicates that HUTCHMED (China) Limited files annual reports under cover of Form 20-F.
What is the SIC code for HUTCHMED (China) Limited?
The Standard Industrial Classification (SIC) code for HUTCHMED (China) Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 173 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2025-08-25 06:15:40
Filing Documents
- hcm-20250825x6k.htm (6-K) — 22KB
- hcm-20250825xex99d1.htm (EX-99.1) — 26KB
- hcm-20250825xex99d2.htm (EX-99.2) — 20KB
- hcm-20250825xex99d1001.gif (GRAPHIC) — 4KB
- hcm-20250825xex99d2001.gif (GRAPHIC) — 4KB
- 0001648257-25-000057.txt ( ) — 80KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2025 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Announcement relating to appointment of acting chief executive officer Exhibit 99.2 Press release relating to appointment of acting chief executive officer 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: August 25, 2025 3